Nuvation Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	169.9	62.9	7.87	-	-	-
Revenue Growth	1083.56%	698.96%	-	-	-	-
Cost of Revenue	20.09	9.3	7.08	-	-	-
Gross Profit	149.81	53.6	0.8	-	-	-
Selling, General & Admin	158.59	151.56	69.23	28.53	31.92	24.28
Research & Development	128.85	115.11	99.12	71.29	87.82	65.25
Operating Expenses	287.44	266.67	168.35	99.82	119.73	89.53
Operating Income	-137.63	-213.06	-167.56	-99.82	-119.73	-89.53
Interest Expense	-26.67	-13.68	-0.34	-	-	-
Interest & Investment Income	21.03	21.43	27.06	24.61	7.45	2.96
Other Non Operating Income (Expenses)	2.89	0.72	-2.02	-0.45	9.32	3.59
EBT Excluding Unusual Items	-140.38	-204.6	-142.86	-75.66	-102.97	-82.98
Gain (Loss) on Sale of Investments	0.02	0.01	-0.01	-0.14	-1.23	-0.08
Gain (Loss) on Sale of Assets	0	-0.03	-	-	-	-
Pretax Income	-149.83	-204.63	-567.94	-75.8	-104.2	-86.85
Net Income	-149.83	-204.63	-567.94	-75.8	-104.2	-86.85
Net Income to Common	-149.83	-204.63	-567.94	-75.8	-104.2	-86.85
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	342	342	269	219	217	198
Shares Outstanding (Diluted)	342	342	269	219	217	198
Shares Change	4.49%	27.07%	22.79%	1.00%	9.52%	102.90%
EPS (Basic)	-0.44	-0.60	-2.11	-0.35	-0.48	-0.44
EPS (Diluted)	-0.44	-0.60	-2.11	-0.35	-0.48	-0.44
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-120.93	-173.78	-130.58	-68.07	-96.48	-68.47
Free Cash Flow Per Share	-0.35	-0.51	-0.49	-0.31	-0.45	-0.35
Gross Margin	88.17%	85.22%	10.10%	-	-	-
Operating Margin	-81.00%	-338.72%	-2128.25%	-	-	-
Profit Margin	-88.19%	-325.31%	-7213.76%	-	-	-
Free Cash Flow Margin	-71.17%	-276.27%	-1658.52%	-	-	-
EBITDA	-135.48	-211.33	-166.87	-99.6	-119.54	-89.35
D&A For EBITDA	2.15	1.74	0.68	0.22	0.2	0.18
EBIT	-137.63	-213.06	-167.56	-99.82	-119.73	-89.53
Revenue as Reported	169.9	62.9	7.87	-	-	-

SEC Filings: 10-K · 10-Q